EDGAR Filing Documents for 0001193125-15-099914

Form 8-K - Current report:

SEC Accession No. 0001193125-15-099914

Filing Date

2015-03-20

Accepted

2015-03-20 13:31:33

Documents

Period of Report

2015-03-19

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d892756d8k.htm	8-K	20865
2	EX-1.1	d892756dex11.htm	EX-1.1	189793
3	EX-5.1	d892756dex51.htm	EX-5.1	25520
4	EX-99.1	d892756dex991.htm	EX-99.1	12656
5	GRAPHIC	g892756ex5_1farris.jpg	GRAPHIC	2780
6	GRAPHIC	g892756ex5_1pg01a.jpg	GRAPHIC	20444
7	GRAPHIC	g892756ex5_1pg01b.jpg	GRAPHIC	10517
8	GRAPHIC	g892756ex99_1logo.jpg	GRAPHIC	9136
	Complete submission text file	0001193125-15-099914.txt		309753

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 15715723
SIC: 2834 Pharmaceutical Preparations